Compare SLN & CTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLN | CTRN |
|---|---|---|
| Founded | 1994 | 1946 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 678.0M | 559.1M |
| IPO Year | 2010 | 2005 |
| Metric | SLN | CTRN |
|---|---|---|
| Price | $11.51 | $50.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $42.60 | ★ $52.00 |
| AVG Volume (30 Days) | ★ 647.9K | 161.9K |
| Earning Date | 05-07-2026 | 06-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 112.14 |
| EPS | N/A | ★ 0.80 |
| Revenue | $559,000.00 | ★ $819,962,000.00 |
| Revenue This Year | N/A | $8.81 |
| Revenue Next Year | N/A | $8.35 |
| P/E Ratio | ★ N/A | $67.54 |
| Revenue Growth | N/A | ★ 8.88 |
| 52 Week Low | $4.19 | $29.60 |
| 52 Week High | $17.58 | $77.91 |
| Indicator | SLN | CTRN |
|---|---|---|
| Relative Strength Index (RSI) | 42.56 | N/A |
| Support Level | $4.70 | N/A |
| Resistance Level | $15.28 | N/A |
| Average True Range (ATR) | 0.58 | 0.00 |
| MACD | -0.23 | 0.00 |
| Stochastic Oscillator | 10.46 | 0.00 |
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for its internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.